Prothrombotic fibrin clot phenotype in obstetric antiphospholipid syndrome: clinical implications and unanswered questions. Authors’ reply

Key Points

• The aim is to explore the clinical implications of the prothrombotic fibrin clot phenotype in obstetric antiphospholipid syndrome and highlight unresolved issues.
• Discussion of clinical observations on fibrin clot characteristics
• Review of potential treatment implications
• Consideration of whether existing data sufficiently addresses the identified issues
• Identified a specific prothrombotic fibrin phenotype in obstetric antiphospholipid syndrome
• Highlighted the need for further investigation into clinical outcomes
• Noted gaps in current research that require attention